Valion Bio, Inc.
VBIO
$2.44
-$0.06-2.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -195.69% | -139.22% | -56.99% | -16.90% | 6.06% |
| Total Depreciation and Amortization | 187.32% | -39.74% | -98.58% | 118.25% | 63.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 63.19% | 73.82% | 71.85% | 452.71% | 310.80% |
| Change in Net Operating Assets | 250.00% | 139.02% | 137.89% | -225.00% | -68.54% |
| Cash from Operations | -165.58% | -124.76% | -22.25% | 0.93% | 16.82% |
| Capital Expenditure | -3,200.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 77.16% | 73.19% | -- | -- | -- |
| Cash from Investing | 59.16% | 64.64% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -84.18% | -47.95% | -44.17% | 9.03% | -58.41% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 2,611.97% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -31.88% | -2,066.67% | -528.57% | 95.54% | -418.46% |
| Cash from Financing | 356.45% | 307.17% | 323.52% | 150.29% | -53.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 151.49% | 792.09% | 864.03% | 142.32% | -342.65% |